KHB Unveils Innovative Polaris V150 Analyzer at MEDICA 2025
At the renowned MEDICA 2025 exhibition, Shanghai Kehua Bio-engineering Co., Ltd. (KHB) presented its cutting-edge Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer. This compact advancement in the field of in-vitro diagnostics (IVD) highlights KHB's dedication to pioneering automated diagnostic solutions.
Revolutionizing Laboratory Diagnostics
Intended for a range of laboratory environments, including small to medium-sized labs, the Polaris V150 is particularly beneficial for STAT and emergency testing procedures in larger healthcare facilities. Its performance combines efficiency, precision, and user-friendliness, integrated into a desktop model that takes up only 0.36 m² of space.
Compact Footprint, High Throughput
Despite its small footprint, the Polaris V150 manages to perform an impressive 150 tests per hour. This capability allows laboratories to maximize operational efficiency, even when faced with limited space. The analyzer supports continuous sample loading and is equipped with a STAT function to prioritize urgent samples, ensuring clinicians have access to critical data when they need it most.
Cutting-Edge Technology for Accurate Results
The Polaris V150 is driven by a sophisticated ALP–AMPPD technology that ensures high accuracy across numerous assays, boasting a coefficient of variation (CV) of less than 3%. Moreover, the analyzer’s all-in-one reagent kit design, featuring QR-coded calibrators, permits standardized operations and seamless reagent management.
A Diverse Range of Assays
With the Polaris V150, KHB offers an expansive test menu that encompasses over 60 assays targeting 10 critical disease panels. These tests are designed to meet diverse diagnostic requirements, from routine checks to more complex evaluations. The offerings cover an extensive range including thyroid function, sex hormones, tumor markers, infectious diseases, and cardiac biomarkers, ensuring that laboratories can address a wide array of health concerns.
Intelligent Design Enhancing Usability
The user experience is notably improved through thoughtful system design. Larger displays and a built-in touchscreen streamline navigation within the platform, reducing the need for extensive training. Users can monitor the status of reagents and consumables in real-time, maintaining oversight of operational readiness throughout their workday.
Ensuring Reliability in Performance
The Polaris V150 is built to deliver consistent performance, featuring onboard refrigeration for up to 12 reagent positions. This capability maintains reagent stability and enhances overall assay reliability. Furthermore, remote monitoring and automated service features mitigate downtime, allowing laboratories to sustain operational continuity.
Welcoming Feedback at MEDICA 2025
During the exhibition, the Polaris V150 garnered significant attention, demonstrating the increasing global demand for effective, compact chemiluminescence systems. KHB’s knowledgeable team conducted live demonstrations and consultations, granting visitors an insightful look into the analyzer's capabilities and its applicability in both routine and emergency laboratory contexts.
"The positive response we've seen at MEDICA reinforces the necessity for high-quality, compact solutions like the Polaris V150," remarked KHB's product manager. "We are thrilled to introduce this advanced technology to our international partners and support laboratories worldwide with innovative immunoassay solutions."
About KHB Group
Shanghai Kehua Bio-engineering Co., Ltd. (KHB, Stock code: 002022.SZ) has established itself as a prominent player in the in-vitro diagnostic landscape, offering a comprehensive array of medical diagnostic products. The company's focus spans various diagnostic methods, including immune diagnostics, biochemical diagnostics, molecular diagnostics, and point-of-care testing (POCT). Founded in 1981, KHB has grown into a high-tech company integrating research, development, manufacturing, and marketing processes. The company became publicly traded on the Shenzhen Stock Exchange in 2004.
Frequently Asked Questions
What is the Polaris V150 Analyzer?
The Polaris V150 is an automatic chemiluminescence immunoassay analyzer that provides high-quality diagnostic tests efficiently.
What type of laboratories is the Polaris V150 designed for?
This analyzer is ideal for small and medium-sized laboratories and larger hospitals needing quick emergency testing.
How many tests per hour can the Polaris V150 handle?
It can perform up to 150 tests per hour, thus increasing laboratory operational efficiency.
What technology powers the Polaris V150?
The analyzer utilizes ALP–AMPPD technology for high accuracy and precision in results.
What is the significance of KHB at MEDICA 2025?
KHB showcased the Polaris V150, drawing significant interest as a leading solution for compact chemiluminescence systems in the medical field.
